Literature DB >> 20098344

Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help.

Ruud H J Verstegen1, Maaike A A Kusters, Eugenie F A Gemen, Esther DE Vries.   

Abstract

Down syndrome (DS) is known for increased incidence of respiratory infections and autoimmune diseases, indicating impaired immunity. Until now, attention has been mainly focused on T lymphocytes. Therefore, we determined B-lymphocyte subpopulations in 95 children with DS compared with 33 age-matched control (AMC) children. DS serum immunoglobulin levels were compared with 962 non-DS children with recurrent infections. The results were combined with clinical data. Transitional and naive B lymphocytes are profoundly decreased in the children with DS. This could be caused by an intrinsic B-lymphocyte defect resulting in (partial) failure of B-lymphocyte generation, decreased antigen-induced proliferation and/or increased apoptosis, or by decreased proliferation due to deficient T-lymphocyte help, or a combination of these. The decreased CD27, CD21, and CD23 cells are reminiscent of common variable immunodeficiency and suggestive of disturbed peripheral B-lymphocyte maturation. Immunoglobulin levels in DS are abnormal-as has been described before-and different from non-DS children with recurrent infections. We conclude that the humoral immune system is abnormal in DS, but could not find a relation between B-lymphocyte subsets, immunoglobulins and clinical features of the children with DS in our cohort, nor could we answer the question whether DS lymphocytes are truly intrinsically deficient, or could all findings be explained by deficient T-lymphocyte help.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20098344     DOI: 10.1203/PDR.0b013e3181d4ecc1

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  23 in total

1.  Down syndrome: is it really characterized by precocious immunosenescence?

Authors:  Maaike Aa Kusters; Ruud Hj Verstegen; Esther de Vries
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

2.  Age-related alterations of the CD19 complex and memory B cells in children with Down syndrome.

Authors:  Ayse Nazli Seckin; Hulya Ozdemir; Ayca Ceylan; Hasibe Artac
Journal:  Clin Exp Med       Date:  2017-02-14       Impact factor: 3.984

3.  Defective thymic progenitor development and mature T-cell responses in a mouse model for Down syndrome.

Authors:  Laureanne P E Lorenzo; Kristen E Shatynski; Sarah Clark; Paul J Yarowsky; Mark S Williams
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

4.  Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21.

Authors:  Anindita Roy; Gillian Cowan; Adam J Mead; Sarah Filippi; Georg Bohn; Aristeidis Chaidos; Oliver Tunstall; Jerry K Y Chan; Mahesh Choolani; Phillip Bennett; Sailesh Kumar; Deborah Atkinson; Josephine Wyatt-Ashmead; Ming Hu; Michael P H Stumpf; Katerina Goudevenou; David O'Connor; Stella T Chou; Mitchell J Weiss; Anastasios Karadimitris; Sten Eirik Jacobsen; Paresh Vyas; Irene Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

Review 5.  Infections and immunodeficiency in Down syndrome.

Authors:  G Ram; J Chinen
Journal:  Clin Exp Immunol       Date:  2011-02-24       Impact factor: 4.330

6.  Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome.

Authors:  Katherine A Waugh; Paula Araya; Ahwan Pandey; Kimberly R Jordan; Keith P Smith; Ross E Granrath; Santosh Khanal; Eric T Butcher; Belinda Enriquez Estrada; Angela L Rachubinski; Jennifer A McWilliams; Ross Minter; Tiana Dimasi; Kelley L Colvin; Dmitry Baturin; Andrew T Pham; Matthew D Galbraith; Kyle W Bartsch; Michael E Yeager; Christopher C Porter; Kelly D Sullivan; Elena W Hsieh; Joaquin M Espinosa
Journal:  Cell Rep       Date:  2019-11-12       Impact factor: 9.423

7.  A Prevalent CXCR3+ Phenotype of Circulating Follicular Helper T Cells Indicates Humoral Dysregulation in Children with Down Syndrome.

Authors:  Giorgio Ottaviano; Jolanda Gerosa; Micaela Santini; Pasqualina De Leo; Andrea Vecchione; Tatiana Jofra; Cristiana Trimarchi; Maurizio De Pellegrin; Massimo Agosti; Alessandro Aiuti; Maddalena Marinoni; Maria Pia Cicalese; Georgia Fousteri
Journal:  J Clin Immunol       Date:  2020-01-28       Impact factor: 8.317

Review 8.  Immunodeficiencies Associated with Abnormal Newborn Screening for T Cell and B Cell Lymphopenia.

Authors:  Soma Jyonouchi; Artemio M Jongco; Jennifer Puck; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2017-03-28       Impact factor: 8.317

9.  Immune evaluation and vaccine responses in Down syndrome: evidence of immunodeficiency?

Authors:  Avni Y Joshi; Roshini S Abraham; Melissa R Snyder; Thomas G Boyce
Journal:  Vaccine       Date:  2011-05-17       Impact factor: 3.641

Review 10.  Revisiting Down syndrome from the ENT perspective: review of literature and recommendations.

Authors:  Maria Ramia; Umayya Musharrafieh; Wajdi Khaddage; Alain Sabri
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-21       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.